Unknown

Dataset Information

0

[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].

ABSTRACT: The new coronavirus (SARS-CoV-2) that causes a severe acute respiratory syndrome emerges in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation. This new SARS-CoV-2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dysregulates innate immunity, the use of treatments directed at modulating or containing this could be of interest. A narrative review was made of the current evidence about immunity against coronavirus and its applicability to SARS-CoV-2. The physiopathogenesis is also described, along with the underlying leucocyte activity, with the intention of clarifying the possible usefulness of inflammatory biomarkers and the development of personalised treatments.

SUBMITTER: Garcia-Salido A 

PROVIDER: S-EPMC7183283 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].

García-Salido Alberto A  

Anales de pediatria 20200425 1

The new coronavirus (SARS-CoV-2) that causes a severe acute respiratory syndrome emerges in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation. This new SARS-CoV-2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dys  ...[more]

Similar Datasets

Unknown SARS-CoV-2 E484K Mutation Narrative Review: Epidemiology, Immune Escape, Clinical Implications, and Future Considerations.
| S-EPMC8820839 | biostudies-literature
Unknown Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.
| S-EPMC9280161 | biostudies-literature
Unknown Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
| S-EPMC10244875 | biostudies-literature
Unknown Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability.
| S-EPMC7499518 | biostudies-literature
Unknown Genotyping coronavirus SARS-CoV-2: methods and implications.
| S-EPMC7184998 | biostudies-literature
Unknown Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
| S-EPMC8007772 | biostudies-literature
Unknown Coronavirus biology and replication: implications for SARS-CoV-2.
| S-EPMC7592455 | biostudies-literature
Unknown Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.
| S-EPMC10145020 | biostudies-literature
Unknown SARS-CoV-2 Evades Immune Detection in Alveolar Macrophages
| S-SCDT-EMBOR-2020-51252V1 | biostudies-other
Unknown Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
| S-EPMC7244084 | biostudies-literature